(Q35789251)

10 August 2017

1 reference

title

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis (English)

1 reference

10 August 2017

0 references

1 reference

3

Paul E Verweij

1 reference

10 August 2017

Monique A S H Mennink-Kersten

series ordinal

1

1 reference

PubMed ID

15172343

10 August 2017

J Peter Donnelly

series ordinal

2

1 reference

PubMed ID

15172343

10 August 2017

language of work or name

1 reference

1 June 2004

1 reference

10 August 2017

9

1 reference

Lancet Infectious Diseases

inferred from page(s)

published in

1 reference

10 August 2017

4

1 reference

10 August 2017

349-357

1 reference

10 August 2017

6

1 reference

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Invasive fungal infections in hematology: new trends

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Two strategies for managing invasive aspergillosis: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Transport of small lons and molecules through the plasma membrane of filamentous fungi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

An extracellular beta-galactofuranosidase from Aspergillus niger and its use as a tool for glycoconjugate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

The effect of pH on glucoamylase production, glycosylation and chemostat evolution of Aspergillus niger

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Utilization of phosphocholine from extracellular complex polysaccharide as a source of cytoplasmic choline derivatives in Penicillium fellutanum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Beta-galactofuranose-containing O-linked oligosaccharides present in the cell wall peptidogalactomannan of Aspergillus fumigatus contain immunodominant epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Heat shock treatment releases Penicillium phosphoglycopeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Aspergillosis. The spectrum of the disease in 98 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

The radiological spectrum of invasive aspergillosis in children: a 10-year review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Receptor-mediated clearance of Aspergillus galactomannan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Detection of Aspergillus galactomannan antigen in foods and antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901045-X

7 January 2021

10.1016/S1473-3099(04)01045-X

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15172343